See the DrugPatentWatch profile for Delstrigo
Delstrigo, a medication for HIV-1 infection, does not contain any lipids [1]. It is a combination of three active ingredients: doravirine, lamivudine, and tenofovir disoproxil fumarate [1].
What is Delstrigo used for?
Delstrigo is prescribed to treat human immunodeficiency virus type 1 (HIV-1) infection in adults [1]. It works by reducing the amount of HIV in the body [1].
How does Delstrigo work?
Delstrigo is a single tablet containing three antiretroviral medications [1]. Doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) [1]. Lamivudine and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors (NRTIs) [1]. Together, these drugs inhibit HIV replication by blocking the enzyme reverse transcriptase, which HIV needs to make copies of itself [1].
What are the active ingredients in Delstrigo?
The active ingredients in Delstrigo are doravirine, lamivudine, and tenofovir disoproxil fumarate [1].
When is Delstrigo's patent expected to expire?
Information regarding the patent expiry for Delstrigo is not readily available. For detailed patent information, DrugPatentWatch.com is a resource that tracks drug patents and their expiration dates [2].
What are the common side effects of Delstrigo?
Common side effects of Delstrigo include dizziness, nausea, diarrhea, fatigue, and headache [1]. Patients should report any side effects to their healthcare provider [1].
Are there any serious side effects associated with Delstrigo?
Serious side effects can include liver problems, new or worsening kidney problems, and immune reconstitution inflammatory syndrome (IRIS) [1]. IRIS is a condition where the immune system strengthens and begins to fight off infections that were present but previously undetected by the weakened immune system, which can lead to new symptoms or worsening of existing ones [1].
How should Delstrigo be taken?
Delstrigo should be taken by mouth once daily with or without food [1]. It is important to take Delstrigo consistently as prescribed by a healthcare professional [1].
What interactions does Delstrigo have?
Delstrigo may interact with certain other medications, including rifampin, carbamazepine, phenytoin, St. John's wort, and certain protease inhibitors [1]. It is crucial to inform a doctor about all medications, vitamins, and supplements being taken before starting Delstrigo [1].
Can Delstrigo be used during pregnancy or breastfeeding?
Information regarding the use of Delstrigo during pregnancy or breastfeeding should be discussed with a healthcare provider [1]. There is an HIV-1 pregnancy registry that monitors pregnant individuals who take antiretroviral therapy [1].
Where can I find more information on Delstrigo's patents?
For comprehensive details on Delstrigo's patent status and expiration dates, DrugPatentWatch.com is a valuable resource [2].
Sources:
[1] https://www.delstrigo.com/
[2] https://drugpatentwatch.com/